Europe is Failing to Curb Tobacco Use – Especially in Women 28/02/2026 Kerry Cullinan Europe is failing to curb tobacco use – particularly in women and girls – and will have the world’s highest prevalence by 2030, the World Health Organization’s (WHO) European region revealed this week. Of the region’s 53 states, tobacco use is highest in Serbia, North Macedonia, Bulgaria and Montenegro – all exceeding 30% prevalence in […] Continue reading -> Attacks on Healthcare Spike as War in Ukraine Enters Fifth Year 24/02/2026 Felix Sassmannshausen As the war in Ukraine grinds into its fifth year, the systematic destruction of healthcare infrastructure is accelerating, with strikes targeting hospitals, ambulances, and medical workers surging by nearly 20 percent in 2025 compared to the previous year, according to a statement by the World Health Organization Europe region (WHO/EURO) released on Tuesday. The cumulative […] Continue reading -> EXCLUSIVE: EU to Pledge €700 Million to Global Fund, Less Than Previous Years 10/02/2026 Felix Sassmannshausen The European Commission intends to significantly cut its contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria, ending a decades-long trend of increasing contributions to the multilateral health organisation. According to research by Health Policy Watch, the Commission plans to pledge €700 million over a four-year span from 2026 to 2029 at the […] Continue reading -> As WHO Debates Global AI Regulation, States Clash Over ‘Data Sovereignty’ 05/02/2026 Felix Sassmannshausen A stark debate over who owns the data in the future of AI and digital health emerged at the World Health Organization (WHO) Executive Board on Wednesday. Low and middle-income countries warned that the rapid deployment of new technologies risks accelerating data extraction and increasing inequality, cautioning that – without strict AI governance, sustainable financing […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> New Flu Strain Sweeping Europe Says WHO; but Vaccines Remain Effective, ECDC Finds 19/12/2025 Felix Sassmannshausen Sudden fever, a severe cough and acute respiratory distress are the familiar onset symptoms of seasonal flu, which has affected WHO’s European Region with unusual intensity and speed this year. As the Northern Hemisphere enters winter, health systems are struggling to manage an epidemic driven by an aggressive, genetically mutated influenza strain A(H3N2) subclade K. […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
Attacks on Healthcare Spike as War in Ukraine Enters Fifth Year 24/02/2026 Felix Sassmannshausen As the war in Ukraine grinds into its fifth year, the systematic destruction of healthcare infrastructure is accelerating, with strikes targeting hospitals, ambulances, and medical workers surging by nearly 20 percent in 2025 compared to the previous year, according to a statement by the World Health Organization Europe region (WHO/EURO) released on Tuesday. The cumulative […] Continue reading -> EXCLUSIVE: EU to Pledge €700 Million to Global Fund, Less Than Previous Years 10/02/2026 Felix Sassmannshausen The European Commission intends to significantly cut its contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria, ending a decades-long trend of increasing contributions to the multilateral health organisation. According to research by Health Policy Watch, the Commission plans to pledge €700 million over a four-year span from 2026 to 2029 at the […] Continue reading -> As WHO Debates Global AI Regulation, States Clash Over ‘Data Sovereignty’ 05/02/2026 Felix Sassmannshausen A stark debate over who owns the data in the future of AI and digital health emerged at the World Health Organization (WHO) Executive Board on Wednesday. Low and middle-income countries warned that the rapid deployment of new technologies risks accelerating data extraction and increasing inequality, cautioning that – without strict AI governance, sustainable financing […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> New Flu Strain Sweeping Europe Says WHO; but Vaccines Remain Effective, ECDC Finds 19/12/2025 Felix Sassmannshausen Sudden fever, a severe cough and acute respiratory distress are the familiar onset symptoms of seasonal flu, which has affected WHO’s European Region with unusual intensity and speed this year. As the Northern Hemisphere enters winter, health systems are struggling to manage an epidemic driven by an aggressive, genetically mutated influenza strain A(H3N2) subclade K. […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
EXCLUSIVE: EU to Pledge €700 Million to Global Fund, Less Than Previous Years 10/02/2026 Felix Sassmannshausen The European Commission intends to significantly cut its contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria, ending a decades-long trend of increasing contributions to the multilateral health organisation. According to research by Health Policy Watch, the Commission plans to pledge €700 million over a four-year span from 2026 to 2029 at the […] Continue reading -> As WHO Debates Global AI Regulation, States Clash Over ‘Data Sovereignty’ 05/02/2026 Felix Sassmannshausen A stark debate over who owns the data in the future of AI and digital health emerged at the World Health Organization (WHO) Executive Board on Wednesday. Low and middle-income countries warned that the rapid deployment of new technologies risks accelerating data extraction and increasing inequality, cautioning that – without strict AI governance, sustainable financing […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> New Flu Strain Sweeping Europe Says WHO; but Vaccines Remain Effective, ECDC Finds 19/12/2025 Felix Sassmannshausen Sudden fever, a severe cough and acute respiratory distress are the familiar onset symptoms of seasonal flu, which has affected WHO’s European Region with unusual intensity and speed this year. As the Northern Hemisphere enters winter, health systems are struggling to manage an epidemic driven by an aggressive, genetically mutated influenza strain A(H3N2) subclade K. […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
As WHO Debates Global AI Regulation, States Clash Over ‘Data Sovereignty’ 05/02/2026 Felix Sassmannshausen A stark debate over who owns the data in the future of AI and digital health emerged at the World Health Organization (WHO) Executive Board on Wednesday. Low and middle-income countries warned that the rapid deployment of new technologies risks accelerating data extraction and increasing inequality, cautioning that – without strict AI governance, sustainable financing […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> New Flu Strain Sweeping Europe Says WHO; but Vaccines Remain Effective, ECDC Finds 19/12/2025 Felix Sassmannshausen Sudden fever, a severe cough and acute respiratory distress are the familiar onset symptoms of seasonal flu, which has affected WHO’s European Region with unusual intensity and speed this year. As the Northern Hemisphere enters winter, health systems are struggling to manage an epidemic driven by an aggressive, genetically mutated influenza strain A(H3N2) subclade K. […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> New Flu Strain Sweeping Europe Says WHO; but Vaccines Remain Effective, ECDC Finds 19/12/2025 Felix Sassmannshausen Sudden fever, a severe cough and acute respiratory distress are the familiar onset symptoms of seasonal flu, which has affected WHO’s European Region with unusual intensity and speed this year. As the Northern Hemisphere enters winter, health systems are struggling to manage an epidemic driven by an aggressive, genetically mutated influenza strain A(H3N2) subclade K. […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa 21/01/2026 Felix Sassmannshausen STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading -> EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> New Flu Strain Sweeping Europe Says WHO; but Vaccines Remain Effective, ECDC Finds 19/12/2025 Felix Sassmannshausen Sudden fever, a severe cough and acute respiratory distress are the familiar onset symptoms of seasonal flu, which has affected WHO’s European Region with unusual intensity and speed this year. As the Northern Hemisphere enters winter, health systems are struggling to manage an epidemic driven by an aggressive, genetically mutated influenza strain A(H3N2) subclade K. […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
EU and US Regulators Reach Landmark Accord on AI Principles in Drug Development 16/01/2026 Felix Sassmannshausen The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading -> New Flu Strain Sweeping Europe Says WHO; but Vaccines Remain Effective, ECDC Finds 19/12/2025 Felix Sassmannshausen Sudden fever, a severe cough and acute respiratory distress are the familiar onset symptoms of seasonal flu, which has affected WHO’s European Region with unusual intensity and speed this year. As the Northern Hemisphere enters winter, health systems are struggling to manage an epidemic driven by an aggressive, genetically mutated influenza strain A(H3N2) subclade K. […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
New Flu Strain Sweeping Europe Says WHO; but Vaccines Remain Effective, ECDC Finds 19/12/2025 Felix Sassmannshausen Sudden fever, a severe cough and acute respiratory distress are the familiar onset symptoms of seasonal flu, which has affected WHO’s European Region with unusual intensity and speed this year. As the Northern Hemisphere enters winter, health systems are struggling to manage an epidemic driven by an aggressive, genetically mutated influenza strain A(H3N2) subclade K. […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts
WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Posts navigation Older postsNewer posts